Position in AZN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,217,767,628
New position
Shares Held
6,174,666
first reported quarter
Ownership
0.398%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Swiss National Bank holds $9,095,925,651 across 11 Drug Manufacturers - General names. AZN ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,358,310 | $2,169,102,788 | |
| 2 | JNJ |
Johnson & Johnson
|
7,070,707 | $1,728,363,619 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
6,174,666 | $1,217,767,628 | |
| 4 | ABBV |
AbbVie Inc.
|
5,186,810 | $1,128,079,306 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,284,151 | $876,210,523 | |
| 6 | AMGN |
Amgen Inc
|
1,580,353 | $556,047,203 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,641,000 | $507,446,170 | |
| 8 | PFE |
Pfizer Inc
|
16,686,212 | $468,548,832 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,217,767,628 | 6,174,666 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||